Michel Beeri
Michal Schnaider Beeri is a global leader in Alzheimer’s disease clinical research.

The Board of Governors named Michal Schnaider Beeri, a global leader in Alzheimer’s disease clinical research and director of the Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center, as its Endowed Chair in Alzheimer’s and Dementia Research.

Beeri came to Rutgers from the Ichan School of Medicine at Mount Sinai, NY, where she was a professor in psychiatry, in cognitive aging, Alzheimer’s disease and dementia. The recipient of numerous awards from the National Institutes of Health, Beeri has published more than 200 peer-reviewed articles in leading journals and serves on major health and medical editorial boards.

Throughout her career, Beeri has excelled in mentoring students, physician scientists and postdoctoral researchers. She played a pivotal role in establishing the Joseph Sagol Neuroscience Center at Sheba Medical Center in Israel, renowned for its Alzheimer’s and dementia research. Internationally recognized for her groundbreaking work on the link between metabolism, diabetes, obesity and dementia, Beeri is a leading figure in Alzheimer’s disease and dementia prevention research.

Beeri is a professor at Rutgers Robert Wood Johnson Medical School Department of Neurology and a Core Member of the Brain Health Institute. To better understand the causes of Alzheimer’s and dementia and help develop novel therapeutics for its treatment, Beeri is creating cohorts for clinical trials on Alzheimer’s disease and dementia. The knowledge gained from work done at the new center, which opened this fall, will offer hope for both patients and families whose lives have been unequivocally altered by the devastating effects of dementia and Alzheimer’s disease.

The Alzheimer’s Research Center at Rutgers and the research being overseen by Beeri is supported by a $5 million donation from Herbert C. Klein, a Rutgers alumnus and former U.S. congressman who made the gift in memory of his wife, Jacqueline Krieger Klein who died in 2017 after battling Alzheimer’s disease. An estimated 6.5 million Americans live with Alzheimer’s disease, affecting about 190,000 people over the age of 65 in New Jersey alone, according to the Alzheimer’s Association.